CARDIOTOXICITY IN METASTATIC RENAL CELL CARCINOMA (mRCC) PATIENTS TREATED WITH SUNITINIB (SU)

被引：0
|
作者：
Ballatore, Valentina [1 ]
Prati, Veronica [1 ]
Ruatta, Fiorella [1 ]
Galizia, Danilo [1 ]
Grignani, Giovanni [1 ]
Aglietta, Massimo [1 ]
Ortega, Cinzia [1 ]
机构：
[1] Oncol Med Fdn Piemonte Oncol, Ist Ric & Cura Cancro Candiolo, Turin, Italy
来源：
ANTICANCER RESEARCH | 2012年 / 32卷 / 05期
关键词：
CARDIOVASCULAR TOXICITY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
49
引用
收藏
页码：1876 / 1877
页数：2
相关论文
共 50 条
  • [41] A pooled analysis of the efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinoma (mRCC)
    Hutson, T. E.
    Bukowski, R.
    Rini, B. I.
    Gore, M. E.
    Larkin, J. M.
    Figlin, R. A.
    Barrios, C. H.
    Escudier, B.
    Lin, X.
    Fly, K.
    Martell, B.
    Matczak, E.
    Motzer, R. J.
    BJU INTERNATIONAL, 2012, 109 : 5 - 6
  • [42] Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma
    Mego, M.
    Reckova, M.
    Obertova, J.
    Sycova-Mila, Z.
    Brozmanova, K.
    Mardiak, J.
    ANNALS OF ONCOLOGY, 2007, 18 (11) : 1906 - 1907
  • [43] Prospective Evaluation of Sunitinib-Induced Cardiotoxicity in Patients with Metastatic Renal Cell Carcinoma
    Narayan, Vivek
    Keefe, Stephen
    Haas, Naomi
    Wang, Le
    Puzanov, Igor
    Putt, Mary
    Catino, Anna
    Fang, James
    Agarwal, Neeraj
    Hyman, David
    Smith, Amanda M.
    Finkelman, Brian S.
    Narayan, Hari K.
    Ewer, Steven
    ElAmm, Chantal
    Lenihan, Daniel
    Ky, Bonnie
    CLINICAL CANCER RESEARCH, 2017, 23 (14) : 3601 - 3609
  • [44] Unexpected hyperparathyroidism in metastatic renal cell carcinoma patients treated with sunitinib
    Mazzanti, R.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [45] External validation of a sunitinib prognostic nomogram in patients (pts) with metastatic renal cell carcinoma (mRCC).
    Yu, Changhong
    Kattan, Michael W.
    Hutson, Thomas E.
    Hudes, Gary R.
    Yuan, Jinyu
    Valota, Olga
    Motzer, Robert John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [46] Outcome of patients with metastatic chromophobe renal cell carcinoma treated with sunitinib
    Neiman, V.
    Keizman, D.
    Sarid, D.
    Lee, J-L.
    Sella, A.
    Gottfried, M.
    Hammers, H.
    Eisenberger, M.
    Carducci, M.
    Sinibaldi, V.
    Rosenbaum, E.
    Peer, A.
    Neumann, A.
    Mermershtain, W.
    Rouvinov, K. R.
    Berger, R.
    Yildiz, I.
    ANNALS OF ONCOLOGY, 2016, 27
  • [47] Re: Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib
    Garfield, David H.
    Hercbergs, Aleck
    Davis, Paul J.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (12): : 975 - 976
  • [48] Phase I trial sunitinib plus everolimus in patients with metastatic renal cell carcinoma (mRCC)
    Molina, A. M.
    Feldman, D. R.
    Ginsberg, M. S.
    Fischer, P.
    Trinos, M. J.
    Patil, S.
    Motzer, R. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [49] Efficacy and safety of sunitinib malate (SU11248) in bevacizumab-refractory metastatic renal cell carcinoma (mRCC).
    Rini, B. I.
    George, D. J.
    Michaelson, M. D.
    Rosenberg, J. E.
    Bukowski, R. M.
    Sosman, J. A.
    Stadler, W. M.
    Margolin, K.
    Hutson, T. E.
    Baum, C. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 222S - 222S
  • [50] Looking for predictive biomarkers for sunitinib in metastatic renal clear cell carcinoma (mRCC)
    Maroto, P.
    Esteban, E.
    Méndez-Vidal, M. J.
    Fernandez-Parra, E. M.
    Leon, L.
    Perez-Valderrama, B.
    Domenech, M.
    Calderero, V.
    Perez-Gracia, J. L.
    Algaba, F.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S676 - S676
12345